|
Market Closed -
Nasdaq
16:00:00 2026-02-11 EST
|
5-day change | 1st Jan Change | ||
| 21.64 USD | +0.05% |
|
-.--% | +0.42% |
Company Valuation: Avadel Pharmaceuticals plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 1,013 | 2,115 |
| Change | - | 108.86% |
| Enterprise Value (EV) 1 | 977.8 | 1,986 |
| Change | - | 103.14% |
| P/E | -20.5x | 33.7x |
| PBR | 13.7x | 12.3x |
| PEG | 0.3x | -0x |
| Capitalization / Revenue | 5.99x | 7.58x |
| EV / Revenue | 5.78x | 7.12x |
| EV / EBITDA | -24.6x | 118x |
| EV / EBIT | -23.1x | 154x |
| EV / FCF | -32.2x | -143,157x |
| FCF Yield | -3.11% | -0% |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -0.5133 | 0.64 |
| Distribution rate | - | - |
| Net sales 1 | 169.1 | 279.1 |
| EBITDA 1 | -39.72 | 16.88 |
| EBIT 1 | -42.4 | 12.87 |
| Net income 1 | -48.83 | 64.67 |
| Net Debt 1 | -34.93 | -128.9 |
| Reference price 2 | 10.51 | 21.55 |
| Nbr of stocks (in thousands) | 96,362 | 98,153 |
| Announcement Date | 3/3/25 | 5/1/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.12B | |
| 33.76x | 12.26x | 24.76x | 0.58% | 1,060B | |
| 28.75x | 6.35x | 18.21x | 2.07% | 623B | |
| 34.38x | 7.99x | 16.52x | 2.56% | 480B | |
| 103.88x | 5.82x | 24.82x | 2.39% | 352B | |
| 19.43x | 4.75x | 11.8x | 2.78% | 345B | |
| 20.28x | 5.28x | 13.08x | 3.01% | 274B | |
| 20.79x | 4.27x | 12.2x | 2.08% | 249B | |
| 26.09x | 6.8x | 12.11x | 2.44% | 223B | |
| -44.42x | 6.54x | 25.48x | 2.24% | 182B | |
| Average | 26.99x | 6.67x | 17.66x | 2.24% | 379.01B | |
| Weighted average by Cap. | 32.19x | 7.84x | 19.08x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AVDL Stock
- Valuation Avadel Pharmaceuticals plc
Select your edition
All financial news and data tailored to specific country editions
